COGT · Categories · Form 4

COGT - SEC Form 4 insider transactions

Cogent Biosciences Inc. (COGT) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for COGT

• 22d
  SEC Form 4 filed by Ferrante Karen Jean

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 25d
  SEC Form 4 filed by Fairmount Funds Management Llc

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 93d
  Director Fairmount Funds Management Llc sold $127,400,000 worth of shares (3,500,000 units at $36.40) (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 110d
  SEC Form 4 filed by Director Ferrante Karen Jean

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 116d
  Chief Financial Officer Green John L. sold $2,978,360 worth of shares (77,000 units at $38.68), decreasing direct ownership by 37% to 131,834 units (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 116d
  Chief Medical Officer Sachs Jessica sold $3,198,245 worth of shares (82,642 units at $38.70), decreasing direct ownership by 38% to 133,938 units (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 116d
  Chief Legal Officer Kearns Evan sold $2,515,500 worth of shares (65,000 units at $38.70), decreasing direct ownership by 37% to 109,398 units (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 116d
  Chief Scientific Officer Robinson John Edward sold $3,486,600 worth of shares (90,000 units at $38.74), decreasing direct ownership by 39% to 140,002 units (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 127d
  Chief Scientific Officer Robinson John Edward was granted 370,000 shares and covered exercise/tax liability with 139,998 shares (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 127d
  Chief Financial Officer Green John L. was granted 350,000 shares and covered exercise/tax liability with 145,007 shares, increasing direct ownership by 5,337% to 208,834 units (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 127d
  Chief Legal Officer Kearns Evan covered exercise/tax liability with 125,602 shares and was granted 300,000 shares (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 127d
  Chief Medical Officer Sachs Jessica was granted 370,000 shares and covered exercise/tax liability with 154,716 shares, increasing direct ownership by 16,611% to 216,580 units (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 127d
  Chief Commercial Officer Pinnow Cole covered exercise/tax liability with 94,800 shares and was granted 264,000 shares, increasing direct ownership by 357% to 216,650 units (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 127d
  President and CEO Robbins Andrew R was granted 1,025,000 shares and covered exercise/tax liability with 367,497 shares (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 204d
  SEC Form 4 filed by Director Ferrante Karen Jean

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 297d
  SEC Form 4 filed by Director Ferrante Karen Jean

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 324d
  SEC Form 4 filed by Director Ferrante Karen Jean

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 324d
  SEC Form 4 filed by Director Cain Christopher W.

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 324d
  SEC Form 4 filed by Director Ros Matthew

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 324d
  SEC Form 4 filed by Director Shegog Todd

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 324d
  SEC Form 4 filed by Director Harwin Peter Evan

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 324d
  SEC Form 4 filed by Director Morris Arlene

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 387d
  SEC Form 4 filed by Director Ferrante Karen Jean

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 453d
  SEC Form 4 filed by Chief Financial Officer Green John L.

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 453d
  SEC Form 4 filed by Chief Commercial Officer Pinnow Cole

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 453d
  SEC Form 4 filed by Chief Scientific Officer Robinson John Edward

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 453d
  SEC Form 4 filed by Chief Medical Officer Sachs Jessica

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 453d
  SEC Form 4 filed by President and CEO Robbins Andrew R

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 453d
  SEC Form 4 filed by Chief Legal Officer Kearns Evan

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 477d
  SEC Form 4 filed by Director Ferrante Karen Jean

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 570d
  SEC Form 4 filed by Director Ferrante Karen Jean

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 662d
  SEC Form 4 filed by Director Ferrante Karen Jean

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 681d
  SEC Form 4 filed by Director Cain Christopher W.

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 681d
  SEC Form 4 filed by Director Ros Matthew

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 681d
  SEC Form 4 filed by Director Ferrante Karen Jean

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 681d
  SEC Form 4 filed by Director Harwin Peter Evan

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 681d
  SEC Form 4 filed by Director Shegog Todd

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 681d
  SEC Form 4 filed by Director Morris Arlene

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 682d
  Director Fairmount Funds Management Llc converted options into 1,500,000 shares (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 696d
  SEC Form 4 filed by Pinnow Cole

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 753d
  SEC Form 4 filed by Ferrante Karen Jean

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 754d
  Fairmount Funds Management Llc disposed of 286,851 shares and acquired 286,851 shares (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 799d
  Fairmount Funds Management Llc was granted 1,166,666 shares (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 821d
  SEC Form 4 filed by Robinson John Edward

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 821d
  SEC Form 4 filed by Kearns Evan

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 821d
  SEC Form 4 filed by Sachs Jessica

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 821d
  SEC Form 4 filed by Robbins Andrew R

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 821d
  SEC Form 4 filed by Green John L.

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 842d
  SEC Form 4 filed by Ferrante Karen Jean

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 842d
  SEC Form 4 filed by Ros Matthew

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 935d
  SEC Form 4 filed by Ros Matthew

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 935d
  SEC Form 4 filed by Ferrante Karen Jean

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 1025d
  SEC Form 4 filed by Ros Matthew

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 1025d
  SEC Form 4 filed by Ferrante Karen Jean

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 1047d
  SEC Form 4 filed by Fairmount Funds Management Llc

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 1052d
  SEC Form 4 filed by Morris Arlene

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 1052d
  SEC Form 4 filed by Cain Christopher W.

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 1052d
  SEC Form 4 filed by Ferrante Karen Jean

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 1052d
  SEC Form 4 filed by Shegog Todd

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 1052d
  SEC Form 4 filed by Ros Matthew

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)

Other COGT categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends